Catalyst Wire Dossier Catalyst Wire Dossier

Berodual MDI

ipratropium bromide and fenoterol hydrobromide · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Berodual MDI, covering 2014-07-14 to 2014-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients [Phase 3]

See pricing